Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Legend Biotech's share price for the quarter that ended in Mar. 2026 was $18.09. Legend Biotech's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 186 Mil. Therefore, Legend Biotech's market cap for the quarter that ended in Mar. 2026 was $3,360 Mil.
Legend Biotech's quarterly market cap
declined
from Sep. 2025 ($6,023 Mil) to Dec. 2025 ($4,021 Mil) and
declined
from Dec. 2025 ($4,021 Mil) to Mar. 2026 ($3,360 Mil).
Legend Biotech's annual market cap
declined
from Dec. 2023 ($10,946 Mil) to Dec. 2024 ($5,976 Mil) and
declined
from Dec. 2024 ($5,976 Mil) to Dec. 2025 ($4,021 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Legend Biotech's Enterprise Value for Today is $5,240 Mil.
Legend Biotech (NAS:LEGN) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Legend Biotech Market Cap Related Terms
Legend Biotech Market Cap Historical Data
* Premium members only.
The historical data trend for Legend Biotech's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Legend Biotech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Legend Biotech Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Legend Biotech's Market Cap distribution charts can be found below:
* The bar in red indicates where Legend Biotech's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Legend Biotech's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Legend Biotech (LEGN) has a Market Cap of $5,685 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Legend Biotech and its competitors. According to the industry distribution chart, Legend Biotech ranks #73 out of 1428 companies in the Biotechnology industry, placing it in the top 5.1%.
Is Legend Biotech's Market Cap too high?
Legend Biotech's current Market Cap is $5,685 Mil. The Biotechnology industry median Market Cap is 114.03. Legend Biotech's value of $5,685 Mil is 4885.4% above this industry median. Based on the distribution chart, Legend Biotech ranks #73 out of 1428 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Legend Biotech has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Legend Biotech's Market Cap compare to TVTX and ORKA?
According to the Biotechnology industry distribution chart, Legend Biotech ranks #73 out of 1428 companies for Market Cap. This places Legend Biotech in the top 5% of its industry — outperforming the majority of peers. The industry median Market Cap is 114.03. Legend Biotech's value of $5,685 Mil is 4885.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 114.03, based on 1,428 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Legend Biotech's current Market Cap of $5,685 Mil is 4885.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Legend Biotech and its competitors. For the Biotechnology industry, the median Market Cap is 114.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Legend Biotech's current Market Cap is $5,685 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Legend Biotech stock overvalued right now?
Based on GuruFocus' analysis, Legend Biotech (LEGN) is currently considered Possible Value Trap. The stock's GF Value™ is $98.55, compared to a current price of $29.39 — trading 70.2% below its estimated fair value. The current Market Cap is $5,685 Mil and 4885.4% above the Biotechnology industry median of 114.03. Legend Biotech's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Legend Biotech (LEGN), the current Market Cap is $5,685 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Legend Biotech (LEGN) Overvalued in 2026?
Based on GuruFocus' analysis, Legend Biotech stock appears to be undervalued.
The current stock price of $29.39 is trading 70.2% below its estimated GF Value™ of $98.55.
GuruFocus considers Legend Biotech to be Possible Value Trap.
Key valuation signals for LEGN:
Market Cap: $5,685 Mil
GF Value™: $98.55 vs. price of $29.39 (70.2% below fair value)
Industry Position: 4885.4% above the Biotechnology median (#73 of 1428)
No single metric tells the full story. See the LEGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
73GF Score
Get the complete analysis for LEGN
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LEGN has been successfully added to your 
